KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to Oregon

HB3799 • 2025

Creates a method by which a health care practitioner may offer to treat a patient who has a terminal disease or severe chronic disease with an investigational product not approved by the United States Food and Drug Administration.

Creates a method by which a health care practitioner may offer to treat a patient who has a terminal disease or severe chronic disease with an investigational product not approved by the United States Food and Drug Administration.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Representative Bowman, Representative Diehl
Last action
2025-06-27
Official status
In House Committee
Effective date
Not listed

Plain English Breakdown

The plain English breakdown is still being put together. The official documents below are already here.

Bill History

  1. 2025-06-27 House

    In committee upon adjournment.

  2. 2025-03-27 House

    Public Hearing held.

  3. 2025-03-04 House

    Referred to Behavioral Health and Health Care.

  4. 2025-02-27 House

    First reading. Referred to Speaker's desk.

Official Summary Text

Digest: The Act allows doctors to give some patients novel types of treatment. (Flesch Readability Score: 74.8).
Creates a method by which a health care practitioner may offer to treat a patient who has a terminal disease or severe chronic disease with an investigational product not approved by the United States Food and Drug Administration. Provides protections, including a waiver of liability, for health care practitioners, health care facilities, professional organizations or associations and manufacturers or distributors of investigational products that comply with the Act.
Relating to: Relating to medical treatments with investigational products.
Current location: In House Committee